Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Evolent Health, Inc. EVH | WELLINGTON MANAGEMENT GROUP LLP | 10,436,495 9.000% | -3,020,457 (-22.45%) | Filing History |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Evolent Health, Inc. EVH | FMR LLC | 4,522,994 3.883% | -1,797,813 (-28.44%) | Filing History |
| 2024-08-07 07:47 am Purchase | 2024-07-31 | 13G | Evolent Health, Inc. EVH | WELLINGTON MANAGEMENT GROUP LLP | 13,456,952 11.580% | 5,143,795 (+61.88%) | Filing History |
| 2024-07-10 10:10 am Sale | 2024-07-09 | 13G | Evolent Health, Inc. EVH | FMR LLC | 6,320,807 5.429% | -6,569,922 (-50.97%) | Filing History |
| 2024-06-17 8:50 pm Purchase | 2024-06-06 | 13G | Evolent Health, Inc. EVH | RA CAPITAL MANAGEMENT L.P. | 8,279,103 7.100% | 8,279,103 (New Position) | Filing History |
| 2024-04-09 1:17 pm Sale | 2024-03-29 | 13G | Evolent Health, Inc. EVH | JPMORGAN CHASE & CO JPM | 4,679,353 4.000% | -1,184,177 (-20.20%) | Filing History |
| 2024-02-13 5:04 pm Purchase | 2023-12-29 | 13G | Evolent Health, Inc. EVH | VANGUARD GROUP INC | 10,821,331 9.410% | 1,030,515 (+10.53%) | Filing History |
| 2024-02-09 09:03 am Sale | 2024-02-08 | 13G | Evolent Health, Inc. EVH | FMR LLC | 12,890,729 11.213% | -1,750,970 (-11.96%) | Filing History |
| 2024-02-08 10:13 am Purchase | 2023-12-29 | 13G | Evolent Health, Inc. EVH | WELLINGTON MANAGEMENT GROUP LLP | 8,313,157 7.230% | 8,313,157 (New Position) | Filing History |
| 2024-01-26 11:50 am Purchase | 2023-12-31 | 13G | Evolent Health, Inc. EVH | BlackRock Inc. BLK | 8,423,999 7.300% | 722,080 (+9.38%) | Filing History |
| 2024-01-18 08:19 am Purchase | 2023-12-29 | 13G | Evolent Health, Inc. EVH | JPMORGAN CHASE & CO JPM | 5,863,530 5.100% | 494,705 (+9.21%) | Filing History |
| 2023-04-26 4:29 pm Sale | 2023-04-06 | 13G | Evolent Health, Inc. EVH | MAGELLAN HEALTH INC MGLN | 0 0.000% | -8,474,576 (Position Closed) | Filing History |
| 2023-04-10 09:37 am Purchase | 2023-04-06 | 13G | Evolent Health, Inc. EVH | FMR LLC | 14,641,699 13.184% | 12,763,019 (+679.36%) | Filing History |
| 2023-03-08 4:31 pm Sale | 2023-02-28 | 13G | Evolent Health, Inc. EVH | UPMC | 2,190,702 1.970% | -3,717,139 (-62.92%) | Filing History |
| 2023-02-14 2:13 pm Sale | 2022-12-31 | 13G | Evolent Health, Inc. EVH | Granahan Investment Management LLC | 3,155,211 3.120% | -1,843,469 (-36.88%) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | Evolent Health, Inc. EVH | VANGUARD GROUP INC | 9,790,816 9.680% | 2,244,824 (+29.75%) | Filing History |
| 2023-02-03 4:06 pm Sale | 2022-12-31 | 13G | Evolent Health, Inc. EVH | UPMC | 5,907,841 5.840% | -526,442 (-8.18%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Evolent Health, Inc. EVH | BlackRock Inc. BLK | 7,701,919 7.600% | 1,811,956 (+30.76%) | Filing History |
| 2023-01-27 5:24 pm Purchase | 2023-01-20 | 13G | Evolent Health, Inc. EVH | MAGELLAN HEALTH INC MGLN | 8,474,576 8.400% | 8,474,576 (New Position) | Filing History |
| 2023-01-20 12:28 pm Sale | 2022-12-30 | 13G | Evolent Health, Inc. EVH | JPMORGAN CHASE & CO JPM | 5,368,825 5.300% | -743,415 (-12.16%) | Filing History |